Amgen Company Report: Biotechnology, Ethics, and Investment Analysis

This report provides an analysis of Amgen, a leading multinational biopharmaceutical company. It begins with an overview of Amgen's biotechnology operations, emphasizing its reliance on recombinant DNA technologies and its position as a top innovator in the field. The report highlights the importance of intellectual property (IP) protection for Amgen, discussing patents, trademarks, copyrights, and trade secrets as key assets. It also explores the ethical considerations within Amgen, including its commitment to stakeholders, corporate social responsibility (CSR) initiatives, and sustainable practices. The report examines Amgen's supply chain considerations, the role of human resource management, and the company's approach to ethical conduct. The analysis concludes by highlighting the investment potential of Amgen, emphasizing its reputation, ability to overcome barriers like FDA approval, and strong financial performance. References to relevant sources are included to support the analysis.

Running head: BIOTECHNOLOGY
AMGEN COMPANY
Name of the Student:
Name of the University:
Author Note:

1AMGEN COMPANY
Amgen – Summary1
Amgen is the largest multinational pharmaceutical company in America. This
organization provide numerous products related to biotechnology, and the business is based
on recombinant DNA technologies (Amgen Inc, 2020). This organization also comes in the
top position for any innovation in the field of biotechnology and thus, the organization focus
on the IP protection which includes the patent, trademark, copyright along with the trade
secrets. Thus, it is an additional benefit for the investors. As the organization is very
particular about the protection of their IP, and it would assist in filing any infringement cases.
Investors always look for security and IP protection; hence, investors can trust and invest in
the Amgen. Another reason for investment in Amgen is the reputation and recognition it has
built over the years (Amgen, 2020). Amgen is the best-selling drug company with the ability
to overcome barrier such as FDA approval which lead the company in top position. Thus, the
production, lifecycle and revenue would be at the top in the market, and the investors would
be benefited.

2AMGEN COMPANY
Summary 2 (Ethical consideration)
Amgen Company has a strong ethical consideration as they believe and understand
the importance of every stakeholder associated with the organization. Therefore, the
framework and model of operation includes strategies that incorporate managers, employees,
customers and suppliers (Idowu et al., 2013). The corporate social responsibility of the
Amgen is beyond providing medication. They deliver science education and assist the need of
patient with access to medicine with the help of community volunteering (Amgen Inc, 2017).
The company has a useful model for the supply chain, and every supply chain is held
accountable for the compliant supply to the patient with the necessary products. The
organization has set multiple penalties for improper disposal of waste (Chamberlain, 2019).
The outsourcing part has also benefited the organization; however, there are some risks such
as failure of the production that may have a financial impact. The human resource
management played a vital role in formulating code of conduct which includes
accountability, effective communication, safe environment, transparency and collaboration
(Human Resources Edu, 2020). With such vigorous operational activities and ethical
consideration of organization, investors would be benefited.

3AMGEN COMPANY
References
Amgen, Inc. (2017). 2017 RESPONSIBILITY HIGHLIGHTS REPORT, retrieved from
https://www.amgen.com/~/media/amgen/full/www-amgen-com/downloads/responsibi
lity-report/amgen-2017-responsibility-highlights-report.ashx
Amgen. (Aug, 2019). Amgen Wins Patent Case On Enbrel. Retrieved from:
https://www.amgen.com/media/news-releases/2019/08/amgen-wins-patent-case-on-
enbrel-etanercept/
Chamberlain, M. (2019). Consequences of improperly disposed pharmaceuticals. Retrieved
from https://www.danielshealth.com/knowledge-center/pharmaceutical-improper-
disposal-consequences
Human Resources Edu. (2020). What is Human Resource?. Retrieved from
https://www.humanresourcesedu.org/what-is-human-resources/
Idowu, S. O., Zu, L., & Gupta, A. D. (2013). Encyclopedia of corporate social responsibility
(Vol. 21). N.Capaldi (Ed.). Berlin, Germany: Springer.